LLNL’s Innovation and Partnerships Office Assists Effort to Combat the SARS-CoV2 Virus on Several Fronts

Submitted by Anonymous (not verified) on
Bio-Rad Device

Lawrence Livermore National Laboratory’s (LLNL) technology transfer team has opened up multiple fronts to aid the nation’s efforts against the virus that causes COVID-19. IPO is investing in technology maturation and granting royalty-free, non-exclusive licenses for LLNL technologies that could be used against the pandemic.